share_log

Arcus Biosciences shares are trading lower after the company reported Q4 EPS and sales results down from last year.

Benzinga ·  Feb 25, 2021 21:24
Arcus Biosciences shares are trading lower after the company reported Q4 EPS and sales results down from last year.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment